Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates

Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates

US Patent 9011864 · Granted Apr 21, 2015

Estimated economic value: $7,595,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of severe community acquired pneumonia2025
Monoclonal antibodies against Claudin-18 for treatment of cancer2023
Treatment of severe community acquired pneumonia2022
Treatment of severe community acquired pneumonia2021
Monoclonal antibodies against claudin-18 for treatment of cancer2020
Monoclonal antibodies against claudin-18 for treatment of cancer2019
Uses of immunoconjugates targeting CD1382018
Uses of immunoconjugates targeting CD1382018
Uses of immunoconjugates targeting CD1382018
Uses of immunoconjugates targeting CD1382018
Uses of immunoconjugates targeting CD1382018
Monoclonal antibodies against claudin-18 for treatment of cancer2018